2-Fluoro-3-methylphenol | CAS:77772-72-6

We serve 2-Fluoro-3-methylphenol CAS:77772-72-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Fluoro-3-methylphenol

Chemical Name:2-Fluoro-3-methylphenol
CAS.NO:77772-72-6
Synonyms:2-Fluoro-3-methylphenol
2-Fluoro-m-cresol
2-Fluor-3-methylbenzolol
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 174.2±20.0 °C at 760 mmHg
Molecular Formula C7H7FO
Molecular Weight 126.128
Flash Point 67.4±10.5 °C
Vapour Pressure 0.9±0.3 mmHg at 25°C
Index of Refraction 1.520
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 2-Fluoro-3-methylphenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Fluor-3-methylbenzolol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Fluoro-3-methylphenol Use and application,2-Fluoro-m-cresol technical grade,usp/ep/jp grade.


Related News: Chinese nationals coming from China and connecting through another foreign airport will be denied travel. Those with pre-clearance are exempted.3-Fluoro-4-nitrotoluene manufacturer Chinese nationals coming from China and connecting through another foreign airport will be denied travel. Those with pre-clearance are exempted.Octadecyl isocyanate supplier A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA’s concerns.3,4-Dimethoxyaniline vendor There are a number of common signs that you may be infected, most of which are respiratory such as experiencing breathing difficulties, shortness of breath and having a cough.The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.